AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 150 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,000,000 | +48.1% | 488,500 | 0.0% | 0.18% | -0.5% |
| Q4 2018 | $2,701,000 | +2.0% | 488,500 | +62.8% | 0.19% | +22.4% |
| Q3 2018 | $2,649,000 | -3.7% | 300,000 | +8.8% | 0.15% | -5.6% |
| Q2 2018 | $2,751,000 | -4.4% | 275,700 | -8.7% | 0.16% | -12.5% |
| Q1 2018 | $2,879,000 | +66.4% | 302,100 | +159.5% | 0.18% | +97.8% |
| Q4 2017 | $1,730,000 | +176.8% | 116,400 | +266.0% | 0.09% | +173.5% |
| Q3 2017 | $625,000 | +37.1% | 31,800 | 0.0% | 0.03% | +21.4% |
| Q2 2017 | $456,000 | -2.8% | 31,800 | -38.7% | 0.03% | -26.3% |
| Q3 2016 | $469,000 | – | 51,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
| DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
| Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
| Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
| Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
| Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
| Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
| Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
| KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
| Leap Investments LP | 54,700 | $415,000 | 0.61% |